NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. The firm is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and proprietary sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a proprietary platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications.
Follow-Up Questions
NRXBF hissesinin fiyat performansı nasıl?
NRXBF 'in mevcut fiyatı $0.7421 'dir, son işlem günde 0% decreased etti.
Nurexone Biologic Inc için ana iş temaları veya sektörler nelerdir?
Nurexone Biologic Inc Biotechnology endüstrisine ait ve sektör Health Care 'dir
Wall Street analistlerine göre, 5 analist Nurexone Biologic Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 5 al, 1 tut, 0 sat ve 3 güçlü sat içermektedir
